Skip to content

Released May 15, 2019, after the close

10-Q filed May 15, 2019, 45 days after period end · 0001390478-19-000030

Q1 2019 · 10-Q
Revenue—
Net Income-$4.54MN/M vs Q1 2018N/M vs Q4 2018
EPS Diluted-$11.12N/M vs Q1 2018no prior Q4 2018 on file
Operating Cash Flow-$4,991,000N/M

What the release said

The release

Same quarter

MetricQ1 2019Q1 2018Q1 2017Q1 2016
Net Income-$4.54M-$8.00M-$4.60M-$16.49M
EPS Diluted-$11.12-$1.67-$3.63—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR